The molecular genetics of Gelanzmann's thrombasthenia

Platelets

Volumn 9, Issue 1, 1998, Pages 5-20

  French, D L ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; FIBRINOGEN RECEPTOR;

GENE MUTATION; GLANZMANN DISEASE; HUMAN; MOLECULAR GENETICS; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN TRANSPORT; RECEPTOR BINDING; RECEPTOR GENE; REVIEW; THROMBOCYTE AGGREGATION;

EID: 0031929048     PISSN: 09537104     EISSN: None     Source Type: Journal    
DOI: 10.1080/09537109876951     Document Type: Review

References (154)

1. French DL, Coller BS. Hematologically important mutations: Glanzmann thrombasthenia. Blood Cells, Mol Dis 1996; 23: 39-51.
2. George JN, Caen JP, Nurden AT. Glanzmann's thrombasthenia: the spectrum of clinical disease. Blood 1990; 75: 1383-95.
3. Coller BS, Seligsohn U, Peretz H, Newman PJ. Glanzmann thrombasthenia: new insights from an historical perspective. Sem Hematol 1994; 31: 301-11.
4. Phillips DR, Charo IF, Parise LV, Fitzgerald LA. The platelet membrane glycoprotein IIb-IIIa complex. Blood 1988; 71: 831-43.
5. Phillips DR, Charo IF, Scarborough RM. GPIIb-IIIa. The responsive integrin. Cell 1991; 65: 359-62.
6. Calvete JJ. Clues for understanding the structure and function of a prototypic human integrin: the platelet glycoprotein IIb/IIIa complex. Thromb Haemostas 1994; 72: 1-15.
7. 3, the fibrinogen receptor. Proc Soc Exp Biol Med 1995; 208: 346-60.
8. Bray PF. Inherited diseases of platelet glycoproteins: considerations for rapid molecular characterization. Thromb Haemostas 1994; 72: 492-502.
9. Glanzmann E. Hereditare hamorrhagische thrombasthenie: ein beitrag zur pathologie der blut plattchen. J Kinderke 1918; 88: 1-13.
10. Nurden AT, Caen JP. An abnormal platelet glycoprotein pattern in three cases of Glanzmann's thrombasthenia. Br J Haematol 1974; 28: 253-60.
11. Phillips DR, Jenkins CSP, Luscher EF, Larrieu M-J. Molecular differences of exposed surface proteins on thrombasthenic platelet plasma membranes. Nature 1975; 257: 599-600.
12. Duperray A, Troesch A, Berthier R, Chagnon E, Frachet P, Uzan G, Marguerie G. Biosynthesis and assembly of platelet GPIIb-IIIa in human megakaryocytes: evidence that assembly between pro-GPIIb and GPIIIa is a prerequisite for expression of the complex on the cell surface. Blood 1989; 74: 1603-11.
13. O'Toole TE, Loftus JC, Plow EF, Glass AA, Harper JR, Ginsberg MH. Efficient surface expression of platelet GPIIb-IIIa requires both subunits. Blood 1989; 74: 14-8.
14. Rosa J-P, McEver RP. Processing and assembly of the integrin, glycoprotein IIb-IIIa, in HEL cells. J Biol Chem 1989; 264: 12596-603.
15. Poncz M, Risman R, Heidenreich R, Silver SM, Vilaire G, Surrey S,-Schwartz E, Bennett JS. Structure of the platelet membrane glycoprotein IIb. J Biol Chem 1987; 262: 8476-82.
16. Heidenreich R, Eisman R, Surrey S, Delgrosso K, Bennett JS, Schwartz E, Poncz M. Organization of the gene for platelet glycoprotein IIb. Biochemistry 1990; 29: 1232-44.
17. Fitzgerald LA, Steiner B, Rall RCJ, Lo S-S, Phillips DR. Protein sequence of endothelial glycoprotein IIIa derived from a cDNA clone. J Biol Chem 1987; 262: 3936-9.
18. Zimrin AB, Gidwitz S, Lord S, Schwartz E, Bennett JS, White GCI, Poncz M. The genomic organization of platelet glycoprotein IIIa. J Biol Chem 1990; 265: 8590-5.
19. 3 integrin gene. Blood 1994; 83: 668-76.
20. Hynes RO. Integrins: a family of cell surface receptors. Cell 1987; 48: 549-54.
21. Ginsberg MH, Loftus JC, Plow EF. Cytoadhesins, integrins, and platelets. Thromb Haemostas 1988; 59: 1-6.
22. Uzan G, Prenant M, Prandini M-H, Martin F, Marguerie G. Tissue-specific expression of the platelet GPIIb gene. J Biol Chem 1991; 266: 8932-39.
23. Block KL, Poncz M. Platelet glycoprotein IIb gene expression as a model of megakaryocyte-specific expression. Stem Cells 1995; 13: 135-45.
24. Prandini M-H, Uzan G, Martin F, Thevenon D, Marguerie G. Characterization of a specific erythromegakaryocytic enhancer within the glycoprotein IIb promoter. J Biol Chem 1992; 267: 10370-4.
25. Denarier E, Martin F, Martineau S, Marguerie G. PCR cloning and sequence of the murine GPIIb promoter. Biochem Biophys Res Commun 1993; 195: 1360-4.
26. Block KL, Shou Y, Poncz M. An Ets/Sp1 interaction in the 5′-flanking region of the megakaryocyte-specific αIIb gene appears to stabilize Sp1 binding and is essential for expression of this TATA-less gene. Blood 1996; 88: 2071-80.
27. Cheresh DA, Berliner SA, Vincente V, Ruggeri ZM. Recognition of distinct adhesive sites on fibrinogen by related integrins on platelets and endothelial cells. Cell 1989; 58: 945-53.
28. Wagner CL, Mascelli MA, Neblock DS, Weisman HF, Coller BS, Jordan RE. Analysis of GPIIb/IIIa receptor number by quantitation of 7E3 binding to human platelets. Blood 1996; 88: 907-14.
29. Coller BS, Cheresh DA, Asch E, Seligsohn U. Platelet vitronectin receptor expression differentiates Iraqi-Jewish from Arab patients with Glanzmann thrombasthenia in Israel. Blood 1991; 77: 75-83.
30. Reverter JC, Beguin S, Kessels H, Kumar R, Hemker HC, Coller BS. Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. J Clin Invest 1996; 98: 863-74.
31. Seligsohn U, Rososhansky S. A Glanzmann's thrombasthenia cluster among Iraqi Jews in Israel. Thromb Haemost 1984; 52: 230-1.
32. Reichert N, Seligsohn U, Ramot B. Clinical and genetic aspects of Glanzmann's thrombasthenia in Israel. Thromb Diathesis Haem 1975; 34: 9806-20.
33. Awidi AS. Increased incidence of Glanzmann's thrombasthenia in Jordan compared with Scandinavia. Scand J Haematol 1983; 30: 218-22.
34. Khanduri U, Pulimood R, Sudarsanam A, Carman RH, Jadhav M, Pereira S. Glanzmann's thrombasthenia. A review and report of 42 cases from South India. Thromb Haemostas 1981; 46: 717-21.
35. IIb gene. Blood 1995; 86: 977-82.
36. Bray PF, Barsh G, Rosa J-P, Juo XY, Magenis E, Shuman MA. Physical linkage of the genes for platelet membrane glycoproteins IIb and IIIa. Proc Natl Acad Sci USA 1988; 85: 8683-7.
37. Sosnoski DM, Emanuel BS, Hawkins AL, van Tuilen P, Ledbetter DH, Nussbaum RL, Kaos F-T, Schwartz E, Phillips DR, Bennett JS, Fitzgerald LA, Poncz M. Chromosomal localization of the genes for the vitronectin and the fibronectin receptors α subunits and for platelet glycoprotein IIb. J Clin Invest 1988; 81: 1993-8.
38. Peretz H, Yakobson E, Korostishevsky M, Usher S, Seligsohn U. Recombination distance between platelet glycoprotein IIB and glycoprotein IIIA genes. Thromb Haemostas 1995; 73: 1195. (Abstract).
39. Newman PJ, Seligsohn U, Lyman S, Coller BS. The molecular genetic basis of Glanzmann thrombasthenia in the Iraqi-Jewish and Arab populations in Israel. Proc Natl Acad Sci USA 1991; 88: 3160-4.
40. Burk CD, Newman PJ, Lyman S, Gill J, Coller BS, Poncz M. A deletion in the gene for glycoprotein IIb associated with Glanzmann's thrombasthenia. J Clin Invest 1991; 87: 270-6.
41. Poncz M, Rifat S, Coller BS, Newman PJ, Shattil SJ, Parrella T, Fortina P, Bennett JS. Glanzmann thrombasthenia secondary to a Gly273Asp mutation adjacent to the first calcium-binding domain of platelet glycoprotein IIb. J Clin Invest 1994; 93: 172-9.
42. Chen FP, Coller BS, Weiss HJ, Xu LZ, French DL. Glanzmann thrombasthenia due to a glycoprotein IIb missense mutation Leu214Pro. Thromb Haemostas 1995; 73: 1191. (Abstract).
43. 3) in a Chinese patient with Glanzmann's thrombasthenia. Blood 1996; 88: 1666-75.
44. French DL, Chen F, Xu L, Coller BS. A common Arg584Stop mutation in glycoprotein (GP) IIb in 2 additional patients with Glanzmann thrombasthenia. Blood 1996; 88: 30a, (Abstract).
45. Phillips DR, Agin PP. Platelet plasma membrane glycoproteins. Evidence for the presence of nonequivalent disulfide bonds using nonreduced-reduced two-dimensional gel electrophoresis. J Biol Chem 1977; 252: 2121-6.
46. Kolodziej MA, Vilaire G, Rifat S, Poncz M, Bennett JS. Effect of deletion of glycoprotein IIb exon 28 on the expression of the platelet GPIIb/IIIa complex. Blood 1991; 74: 14-8.
47. Handagama P, Rappolee DA, Werb Z, Levin J, Bainton DF. Platelet α-granule fibrinogen, albumin, and immunoglobulin G are not synthesized by rat and mouse megakaryocytes. J Clin Invest 1990; 86: 1364-8.
48. Harrison P. Platelet α-granular fibrinogen. Platelets 1992; 3: 1-11.
49. Harrison P, Wilbourn B, Debili N, Vainchenker W, Breton-Gorius J, Lawrie AS, Masse J-M, Savidge GF, Cramer EM. Uptake of plasma fibrinogen into the alpha granules of human megakaryocytes and platelets. J Clin Invest 1989; 84: 1320-4.
50. 3 integrins in platelet protein trafficking. Blood 1991; 78: 2603-10.
51. 3 (glycoprotein IIb-IIIa). Blood 1993; 82: 135-8.
52. Hardisty R, Pidard D, Cox A, Nokes T, Legrand C, Bouillot C, Pannocchia A, Heilmann E, Hourdille P, Bellucci S, Nurden A. A defect of platelet aggregation with an abnormal distribution of glycoprotein IIb-IIIa complexes within the platelet. Blood 1992; 80: 696-708.
53. Jin Y, Dietz HC, Montgomery RA, Bell WR, McIntosh I, Coller BS, Bray PF. Glanzmann thrombasthenia. Cooperation between sequence variants in cis during splice site selection. J Clin Invest 1996; 98: 1745-54.
54. Morse DE, Yanofsky C. Polarity and the degradation of mRNA. Nature 1969; 224: 329-31.
55. Peltz SW, Brown AH, Jacobson A. Regulation of mRNA turnover in eukaryotic cells. Crit Rev Eukaryot Gene Expres 1993; 1: 99-126.
56. Peltz SW, Feng H, Welch E, Jacobson A. Nonsense-mediated mRNA decay in yeast. Prog Nucl Acid Res Mol Biol 1994; 47: 271-98.
57. Hagan KW, Ruiz-Echevarria MJ, Quan Y, Peltz SW. Characterization of cis-acting sequences and decay intermediates involved in nonsense-mediated mRNA turnover. Mol Cell Biol 1995; 15: 809-23.
58. Baserga SJ, Benz EJJ. Nonsense mutations in the human β-globin gene affect mRNA metabolism. Proc Natl Acad Sci USA 1988; 85: 2056-60.
59. Kato A, Yamamoto K, Miyazaki S, Jung SM, Moroi M, Aoki N. Molecular basis for Glanzmann's thrombasthenia (GT) in a compound heterozygote with glycoprotein IIb gene: a proposal for the classification of GT based on the biosynthetic pathway of glycoprotein IIb-IIIa complex. Blood 1992; 79: 3212-8.
60. Gu JM, Xu WF, Wang XD, Wu QY, Chi CW, Ruan CG. Identification of a nonsense mutation at amino acid 584-arginine of platelet glycoprotein IIb in patients with type I Glanzmann thrombasthenia. Br J Haematol 1993; 83: 442-9.
61. Vinciguerra C, Trzeciak MC, Philippe N, Frappaz D, Reynaud J, Dechavanne M, Negrier C. Molecular study of Glanzmann thrombasthenia in 3 patients issued from 2 different families. Thromb Haemost 1994; 74: 822-7.
62. Tomiyama Y, Kashiwagi H, Kosugi S, Shiraga M, Kanayama Y, Kurata Y, Matsuzawa Y. Abnormal processing of the glycoprotein IIb transcript due to a nonsense mutation in exon 17 associated with Glanzmann's thrombasthenia. Thromb Haemost 1995; 73: 756-62.
63. Zhang S, Ruiz-Echevarria MJ, Quan Y, Peltz SW. Identification and characterization of a sequence motif involved in nonsense-mediated mRNA decay. Mol Cell Biol 1995; 15: 2231-44.
64. French DL, Chen FP, Xu L, Weiss HJ, Coller BS. Two unrelated doubly heterozygous patients with Glanzmann thrombasthenia have the same GPIIb mutation resulting in loss of the transmembrane domain. Thromb Haemost 1997; 77: 360 (Abstract)
65. Djaffar I, Caen JP, Rosa J-P. A large alteration in the human platelet glycoprotein IIIa (integrin β3) gene associated with Glanzmann's thrombasthenia. Hum Mol Genet 1993; 2: 2183-5.
66. 3 complex in a variant type of Glanzmann thrombasthenia. Blood 1994; 84: 244a, (Abstract).
67. Bray PF, Shuman MA. Identification of an abnormal gene for the GPIIIa subunit of the platelet fibrinogen receptor resulting in Glanzmann thrombasthenia. Blood 1990; 75: 881-8.
68. Li L, Bray PG. Homologous recombination among three intragene Alu sequences causes an inversion-deletion resulting in the hereditary bleeding disorder Glanzmann thrombasthenia. Am J Hum Genet 1993; 53: 140-9.
69. Jin Y, Dietz HC, Nurden A, Bray PF. Single-strand conformation polymorphism analysis is a rapid and effective method for the identification of mutations and polymorphisms in the gene for glycoprotein IIIa. Blood 1993; 82: 2281-8.
70. Atwch GF, Brickner HE, Zhu X-X, Kazazian HHJ, Forget BG. New amber mutation in a β-thalassemic gene with non-measurable levels of mutant messenger RNA in vivo. J Clin Invest 1988; 82: 557-61.
71. Vinciguerra C, Khelif A, Alemany M, Morle F, Grenier C, Uzan G, Gulino D, Dechavanne M, Negrier C. A nonsense mutation in the GPIIb heavy chain (Ser 870 → stop) impairs platelet GPIIb-IIIa expression. Br J Haematol 1996; 95: 399-407.
72. Iwamoto S, Nishiumi E, Kajii E, Ikemoto S. An exon 28 mutation resulting in alternative splicing of the glycoprotein IIb transcript and Glanzmann's thrombasthenia. Blood 1994; 83: 1017-23.
73. Calvete JJ, Henschen A, Gonzalez-Rodriguez J. Complete localization of the intrachain disulfide bonds and the N-glycosylation points in the α-subunit of human platelet glycoprotein IIb. Biochem J 1989; 261: 561-8.
74. Calvete JJ, Henschen A, Gonzalez-Rodriguez J. Assignment of disulfide bonds in human platelet GPIIIa. A disulfide pattern for the β-subunits of the integrin family. Biochem J 1991; 274: 63-71.
75. Coller BS, Seligsohn U, Little PA. Type I Glanzmann thrombasthenia patients from the Iraqi-Jewish and Arab populations in Israel can be differentiated by platelet glycoprotein IIIa immunoblot analysis. Blood 1987; 69: 1696-703.
76. Seligsohn U, Coller BS, Zivelin A, Plow EF, Ginsberg MH. Immunoblot analysis of platelet glycoprotein IIb in patients with Glanzmann thrombasthenia in Israel. Br J Haematol 1989; 72: 415-23.
77. 3. J Biol Chem 1996; 271: 30544-7.
78. 3 subunit. J Biol Chem 1994; 269: 8754-61.
79. Bennett JS, Kolodziej MA, Vilaire G, Poncz M. Determinants of the intracellular fate of truncated forms of the platelet glycoprotein IIb and IIIa. J Biol Chem 1993; 268: 3580-5.
80. 3) is a second mutation in Iraqi Jews that stemmed from a distinct founder. Blood 1997; 89: 3654-62.
81. Peretz H, Rosenberg N, Usher S, Graff E, Newman PJ, Coller BS, Seligsohn U. Glanzmann's thrombasthenia associated with deletion-insertion and alternative splicing in the glycoprotein IIb gene. Blood 1995; 85: 414-20.
82. Calvete JJ, Mann K, Alvarez MV, Lopez MM, Gonzalez-Rodriguez J. Proteolytic dissection of the isolated platelet fibrinogen integrin GPIIb/IIIa. Localization of GPIIb and GPIIIa sequences putatively involved in the subunit interface and in intrasubunit and intrachain contacts. Biochem J 1992; 282: 523-32.
83. Kolodziej MA, Vilaire G, Gonder D, Poncz M, Bennett JS. Study of the endoproteolytic cleavage of platelet glycoprotein IIb using oligonucleotide-mediated mutagenesis. J Biol Chem 1991; 266: 23499-504.
84. 3 integrin subunit association. Blood 1997; 90: 3082-8.
85. Simsek S, Heyboer H, de Bruijne-Admiraal LG, Goldschmeding R, Cuijpers HTM, von dem Borne AEGK. Glanzmann's thrombasthenia caused by homozygosity for a splice defect that leads to deletion of the first coding exon of the glycoprotein IIIa mRNA. Blood 1993; 81: 2044-9.
86. 45calcium with platelets unable to aggregate due to thrombasthenia or prolonged calcium deprivation. Br J Haematol 1980; 46: 247-56.
87. 2+ on the surface of platelets. J Clin Invest 1984; 73: 626-32.
88. Tuckwell DS, Brass A, Humphries MJ. Homology modelling of integrin EF-hands. Evidence for widespread use of a conserved cation-binding site. Biochem J 1992; 285: 325-31.
89. 2+-binding properties of the platelet glycoprotein IIb ligand-interacting domain. J Biol Chem 1992; 267: 1001-7.
90. 3 subunit. J Biol Chem 1996; 271: 21978-84.
91. 3 complex. J Biol Chem 1994; 269: 4450-7.
92. ++-binding domain. Blood 1995; 86: 452a, (Abstract).
93. 3. Blood 1996; 88: 167-73.
94. Wilcox DA, Paddock CM, Lyman S, Gill JC, Newman PJ. Glanzmann thrombasthenia resulting from a single amino acid substitution between the second and third calcium-binding domains of GPIIb. J Clin Invest 1995; 95: 1553-60.
95. 327→GPIIb associated to thrombasthenia exerts a dominant negative effect in stably transfected CHO cells. Thromb and Haemost 1996; 76: 292-301.
96. Jackson DE, Poncz M, Holyst MT, Newman PJ. Inherited mutations within the calcium-binding sites of the integrin αIIb subunit (Platelet glycoprotein IIb). Effects of the amino acid side chain and the amino acid position on cation binding. Eur J Biochem 1996; 240: 280-7.
97. Kahn MJ, Kieber-Emmons T, Vilarie G, Murali R, Poncz M, Bennett JS. Effects of mutagenesis of GPIIb amino acid 273 on the expression and conformation of the platelet integrin GPIIb-IIIa. Biochemistry 1996; 35: 14304-11.
98. 3 export to the platelet surface. Blood 1997; 90: 669-77.
99. EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Eng J Med 1994; 330: 956-61.
100. Shattil SJ, Ginsberg MH, Brugge JS. Adhesive signaling in platelets. Curr Opin Cell Biol 1994; 6: 695-704.
101. Savage B, Shattil SJ, Ruggeri ZM. Modulation of platelet function through adhesion receptors. J Biol Chem 1992; 267: 11300-8.
102. Weiss HJ. Flow-related platelet deposition on subendothelium. Throm Haemost 1995; 74: 117-22.
103. O'Toole TE, Katagiri Y, Faull RJ, Peter K, Tamura RN, Quaranta V, Loftus JC, Shattil SJ, Ginsberg MH. Integrin cytoplasmic domains mediate inside-out signal transduction. J Cell Biol 1994; 124: 1047-59.
104. Kloczewiak M, Timmons S, Lukas TJ, Hawiger J. Platelet receptor recognition site on fibrinogen. Synthesis and structure-function relationship of peptides corresponding to the carboxyterminal segment of the gamma chain. Biochemistry 1984; 23: 1767-74.
105. Farrell DH, Thiagarajan P. Binding of recombinant fibrinogen mutants to platelets. J Biol Chem 1994; 269: 226-31.
106. Suh TT, Holmback K, Jensen NJ, Daugherty CC, Small K, Simon DI, Potter SS, Degen JL. Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice. Genes Dev 1995; 9: 2020-38.
107. 3. EMBO J 1996; 15: 5760-71.
108. Haas TA, Plow EF. Integrin-ligand interactions: a year in review. Curr Opin Cell Biol 1994; 6: 656-62.
109. Ginsberg MH, Du X, O'Toole TE, Loftus JC. Platelet integrins. Thromb Haemost 1995; 74: 352-9.
110. 3. J Biol Chem 1996; 271: 2033-9.
111. 214Pro mutation produces Glanzmann thrombasthenia with both quantitative and qualitative abnormalities in GPIIb/IIIa. Blood (in press).
112. Ginsberg MH, Lightsey A, Kunicki TJ, Kaufmann A, Marguerie G, Plow EF. Divalent cation regulation of the surface orientation of platelet membrane glycoprotein IIb. Correlation with fibrinogen binding function and definition of a novel variant of Glanzmann's thrombasthenia. J Clin invest 1986; 78: 1103-11.
113. 3 integrin mutation abolishes ligand binding and alters divalent cation-dependent conformation. Science 1990; 249: 915-8.
114. 214 Arg→Trp mutation. J Clin Invest 1992; 89: 1995-2004.
115. Kouns WC, Steiner B, Kunicki TJ, Moog S, Jutzi J, Jennings LK, Casenave J-P, Lanza F. Activation of the fibrinogen binding site on platelets isolated from a patient with the Strasbourg I variant of Glanzmann's thrombasthenia. Blood 1994; 84: 1108-15.
116. 3 subunit: cation displacement is involved in ligand binding. Cell 1994; 79: 659-67.
117. D'Souza S, Ginsberg MH, Burke T, Lam S, Plow E. Localization of an Arg-Gly-Asp recognition site within an integrin adhesion receptor. Science 1988; 242: 91-3.
118. 3 subunit is sensitive to stimulation. J Biol Chem 1991; 266: 14202-07.
119. Calvete JJ, Arias J, Alvarez MV, Lopez MM, Henshen A, Gonzalez-Rodriguez J. Further studies on the topography of the N-terminal region of human platelet glycoprotein IIIa. Localization of monoclonal epitopes and the putative fibrinogen-binding sites. Biochem J 1991; 274: 457-63.
120. Charo IF, Nannizzi L, Phillips DR, Hsu MA, Scarborough RM. Inhibition of fibrinogen binding to GP IIb-IIIa by a GP IIIa peptide. J Biol Chem 1991; 266: 1415-21.
121. Nurden AT, Rosa J-P, Fournier D, Legrand C, Didry D, Parquet A, Pidard D. A variant of Glanzmann's thrombasthenia with abnormal glycoprotein IIb-IIIa complexes in the platelet membrane. J Clin Invest 1987; 79: 962-69.
122. 214Arg by Trp. Hum Mol Genet 1993; 2: 2179-80.
123. Fournier DJ, Kabral A, Castaldi PA, Berndt MC. A variant of Glanzmann's thrombasthenia characterized by abnormal glycoprotein IIb/IIIa complex formation. Thromb Haemost 1989; 62: 977-83.
124. 3 (platelet glycoprotein IIb-IIIa) helps define a ligand binding site. J Biol Chem 1992; 267: 3789-94.
125. Newman PJ, Weyerbusch-Bottum S, Visentin GP, Gidwitz S, White GCI. Type II Glanzmann thrombasthenia due to a destabilizing amino acid substitution in platelet membrane glycoprotein IIIa. Thromb Haemostas 1993; 69: 1017, (Abstract).
126. Ginsberg MH. Integrins: dynamic regulation of ligand binding. Biochem Soc Trans 1995; 23: 1989-96.
127. 3 (GPIIb/IIIa) receptor function. J Biol Chem 1994; 269: 20913-9.
128. Michishita M, Videm V, Arnaout M. A novel divalent cation-binding site in the A domain of the β2 integrin CR3 (CD11b/ CD18) is essential for ligand binding. Cell 1993; 72: 857-67.
129. Lee J-O, Rieu P, Arnaout MA, Liddington R. Crystal structure of the A domain from the α subunit of integrin CR3 (CD11b/CD18). Cell 1995; 80: 631-8.
130. Lee J-O, Bankston LA, Arnaout MA, Liddington RC. Two conformations of the integrin A-domain (I-domain): a pathway for activation? Structure 1995; 3: 1333-40.
131. Baker EK, Tozer EC, Pfaff M, Shattil SJ, Loftus JC, Ginsberg MH. A genetic analysis of integrin function: Glanzmann thrombasthenia in vitro, Proc Natl Acad Sci USA 1997; 94: 1973-8.
132. Peyruchaud O, Nurden AT, Bourre F. Use of PCR-SSCP to screen the exons of the GP IIb and GP IIIa genes of a variant with Glanzmann thrombasthenia: a mutation in the nucleotide sequence for the GFFKR cytoplasmic domain of the integrin subunit αIIb (GPIIb). Thromb Haemostas 1995; 73: 1189, (Abstract).
133. 3 (glycoprotein IIb-IIIa) in a variant of Glanzmann thrombasthenia. Proc Natl Acad Sci USA 1992; 89: 10164-73.
134. Sims PJ, Ginsbery MH, Plow EF, Shattil SJ. Effect of platelet activation on the conformation of the plasma membrane glycoprotein IIb-IIIa complex. J Biol Chem 1991; 266: 7345-52.
135. 3 integrin (platelet GPIIb-IIIa) is an intrinsic property of the receptor. Cell Reg 1990; 1: 883-93.
136. Ginsberg MH. Cell adhesion: the cytoplasmic face. Biochem Soc Trans 1995; 23: 1989-95.
137. Williams MJ, Hughes PE, O'Toole TE, Ginsberg MH. The inner world of cell adhesion: integrin cytoplasmic domains. Trends Cell Biol 1994; 4: 109-12.
138. IIb. Science 1991; 254: 845-7.
139. Hughes PE, O'Toole TE, Ylanne Y, Shattil SJ, Ginsberg MH. The conserved membrane-proximal region of an integrin cytoplasmic domain specifies ligand binding affinity. J Biol Chem 1995; 270: 12411-7.
140. Hughes PE, Diaz-Gonzalez F, Leong L, Wu C, McDonald JA, Shattil SJ, Ginsberg MH. Breaking the integrin hinge. A defined structural constraint regulates integrin signaling. J Biol Chem 1996; 271: 6571-4.
141. 3 (Platelet glycoprotein IIb IIIa). Blood 1994; 84: 1857-65.
142. 3 subunit. J Biol Chem 1995; 270: 9550-7.
143. Shattil SJ, Hoxie JA, Cunningham M, Brass LF. Changes in the platelet membrane glycoprotein IIb-IIIa complex during platelet activation. J Biol Chem 1985; 260: 11107-14.
144. 3) results in an unstable GPIIb-IIIa complex that retains partial function in a novel form of Glanzmann thrombasthenia. Blood 1996; 88: 280a, (Abstract).
145. 3 (glycoprotein IIb-IIIa) to fibrinogen and liquid-mimetic antibodies (PAC-1, OP-G2, and LJ-CP3). J Biol Chem 1996; 271: 18610-5.
146. Irie A, Kamata T, Puzon-McLaughlin W, Takada Y. Critical amino acid residues for ligand binding are clustered in a predicted β-turn of the third N-terminal repeat in the integrin α4 and α5 subunits. EMBO J 1995; 14: 5550-6.
147. Kirchmaier CM, Westrup D, Becker-Hagendorff K, Just M, Jablonka B, Seifried E. A new variant of Glanzmann thrombasthenia (Frankfurt 1). Thromb Haemostas 1995; 73: 1058, (Abstract).
148. IIc176/IIIa (Frankfurt I) in mammalian cells. Thromb Haemost 1977; 77: 671 (abstract).
149. Cooper DN, Youssoufian H. The CpG dinucleotide and human genetic disease. Hum Genet 1988; 78: 151-5.
150. Ramsahoye BH, Davies CS, Mills KI. DNA methylation: biology and significance. Blood Rev 1996; 10: 249-61.
151. Coller BS, Seligsohn U, Zivelin A, Zwang E, Lusky A, Modan M. Immunologic and biochemical characterization of homozygous and heterozygous Glanzmann thrombasthenia in the Iraqi-Jewish and Arab populations in Israel: comparison of techniques for carrier detection. Br J Haematol 1986; 62: 723-35.
152. Peretz H, Seligsohn U, Zwang E, Coller BS, Newman PJ. Detection of the Glanzmann's thrombasthenia mutations in Arab and Iraqi-Jeuish patients by polymerase chain reaction and restriction analysis of blood or urine samples. Thromb Haemost 1991; 66: 500-4.
153. Seligsohn U, Mibashan RS, Rodeck CH, Nicolaides KH, Millar DS, Coller BS. Prenatal diagnosis of Glanzmann's thrombasthenia. Lancet 1985; II: 1419, (Letter).
154. French DL, Coller BS, Seligsohn U, Peretz H. Prenatal diagnosis of Glanzmann thrombasthenia using the polymorphic markers BRCA1 and THRA1 on chromosome 17. Blood 1996; 88: 30a.